comparemela.com
6
7
8
9
10
11
12
Latest Breaking News On - Electrodiagnostic medicine - Page 5 : comparemela.com
Cipaglucosidase/Miglustat for Pompe Disease: The Long-Term Safety, Efficacy
Treatment with cipaglucosidase/miglustat up to 104 weeks is safe and effective for ambulatory patients with late-onset Pompe disease.
Phoenix
Arizona
United-states
American-association-of-neuromuscular-electrodiagnostic-medicine
Electrodiagnostic-medicine
Annual-meeting
How Do Neuromuscular Diseases Affect Prevalence of Neuropsychiatric Conditions?
The presence of neuropsychiatric conditions, such as depression, is more prevalent among patients with neuromuscular diseases.
Arizona
United-states
Phoenix
National-inpatient-sample
American-association-of-neuromuscular-electrodiagnostic-medicine
Electrodiagnostic-medicine
Annual-meeting
Subcutaneous Immunoglobulin Maintains HRQoL Among Patients With CIDP
In patients with CIDP, health-related quality of life with IVIg was also maintained with facilitated subcutaneous immunoglobulin treatment.
Phoenix
Arizona
United-states
American-association-of-neuromuscular-electrodiagnostic-medicine
Electrodiagnostic-medicine
Annual-meeting
Rasch-built-overall-disability-scale
Item-short-form
Treatment-satisfaction-questionnaire
Neurofilament Light Chain Levels Decrease With Treatment in hATTR Amyloidosis
Neurofilament light chain (NfL) levels may be useful for monitoring disease progression in patients with hATTR amyloidosis.
Phoenix
Arizona
United-states
American-association-of-neuromuscular-electrodiagnostic-medicine
Electrodiagnostic-medicine
Annual-meeting
Which Treatments for Myasthenia Gravis Better Improve HRQoL Outcomes?
Among patients with myasthenia gravis, health-related quality of life outcomes better improve with efgartigimod compared to new therapies.
Arizona
United-states
Phoenix
American-association-of-neuromuscular-electrodiagnostic-medicine
Electrodiagnostic-medicine
Annual-meeting
vimarsana © 2020. All Rights Reserved.